Anand Patel, Assistant Professor of Medicine; Medical Director, Inpatient Leukemia Service
Anand Patel, MD, is board-certified hematologist-oncologist and an expert in treating myeloproliferative neoplasms, myelodysplastic syndromes, and leukemia. In addition to providing his patients with standard treatment approaches such as chemotherapy and targeted therapies, Dr. Patel is also committed to delivering novel therapies through clinical trials that combine basic and translational research into groundbreaking advancements in medicine for better outcomes and quality of life.
Dr. Patel’s research interests are geared towards the development of clinical trials that help improve the standard of care for patients with high-risk leukemias and myeloid malignancies. His research has been published in several peer-reviewed journals, such as Blood, Blood Advances, British Journal of Haematology, Cancer, and JCI Insight.
Financial relationships
-
Attribution:SelfType of financial relationship:OtherIneligible company:AbbVieTopic:Advisory BoardDate added:05/04/2023Date updated:04/04/2024Relationship end date:03/25/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:Bristol Myers SquibbTopic:Advisory BoardDate added:05/04/2023Date updated:04/04/2024Relationship end date:12/10/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:PfizerTopic:research funding to institution for trialDate added:05/04/2023Date updated:04/04/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Kronos BioTopic:research funding to institution for trialDate added:05/04/2023Date updated:04/04/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:SumitumoTopic:research funding to institution for trialDate added:05/04/2023Date updated:04/04/2024